Airway diseases
Interstitial lung diseases
Symposium
Organoids and pluripotent stem cells
Basic science
Disease modelling and drug testing
Aims : to present and discuss (i) the methods by which gut and lung organoids can be cultured and their uses as disease models in translational research, (ii) the biological basis, methodological approaches and applications of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas) gene editing, and (iii) the technical approaches targeting epigenetic mechanisms that can be used to reprogram gene expression.
Target audience :
Clinical researcher, Paediatrician, Scientist (basic, translational), Student, Trainee
Methods :
Cell and molecular biology
08:30
Intestinal organoids as ex vivo models for personalised medicine in cystic fibrosis
J. Beekman(Utrecht, Netherlands)
COI
-
Description
1
275
08:54
The use of bronchospheres to study chronic lung diseases
M. Konigshoff(Pittsburgh, United States)
COI
-
Description
2
276
09:18
Genome modification with CRISPR/Cas
P. Harrison(Cork, Ireland)
COI
-
Description
3
277
09:42
The potential of epigenetic editing in chronic lung disease
M. Rots(Groningen, Netherlands)
COI
-
Description
4
278
10:06
Optimizing experimental research in respiratory diseases: an ERS Statement
M. Kolb(Hamilton (ON), Canada)
COI
5
279
. . .